课题基金 / 基金详情

A molecular informed therapy for Diffuse Intrinsic Pontine Gliomas (DIPG)

A molecular informed therapy for Diffuse Intrinsic Pontine Gliomas (DIPG)
弥漫性内源性脑桥胶质瘤 (DIPG) 的分子信息疗法
批准号:
10015227
负责人:
Andrea Piunti
金额:
$11.44万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-15 至 2021-08-31

项目摘要

项目成果

Andrea Piunti的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diffuse characterized histone substitution levels and By profilying the epigenome of H3K27M mutant DIPG patient cells I found that H3K27M co-localizes with H3K27 acetylation (H3K27ac). In accordance with previous biochemical data, heterotypic H3K27M- K27ac nucleosomes co-localize with bromodomain proteins at actively transcribed genes, whereas PRC2 is excluded from these regions, suggesting that PRC2 is not sequestered at sites of incorporation of H3K27M. I also showed that the heterotypic nucleosomes H3K27M-K27ac co- localize with bromodomain proteins in DIPG, importantly treatment with BET bromodomain inhibitors in DIPG xenograft mouse models potently reduces tumor growth and extend animal survival. During my mentored phase (K99) I'm planning to study the molecular details of the formation of the heterotypic nucleosomes using in vitro biochemistry and molecular biology assays and gather further insights in the pathogenic mechanisms of aberrant acetylation and H3K27M deposition in DIPG. While transitioning toward the independent phase (R00) I'm planning to improve the BET inhibitors therapeutic strategy by identifying mechanisms of resistance and cooperative factors that can lead to an improved and durable therapy for children affected by DIPG. Altogether my plan is to perform experiments that push forward our knowledge of this incurable disease with the goal of finally having a standard-of-care option that can offer a reliable and efficacious treatment for DIPG patients. Intrinsic Glioma (DIP G) a highly aggressive pediatric brainstem tumor by rapid and nearly uniform patient demise. A heterozygous point mutation of H3 occurs in more than 80% of these tumors, and results in a lysine-to-methionine (H3K27M). Expression of this histone mutant is accompanied by a reduction in the of Polycomb Repressive Complex 2 (PRC2) mediated H3K27 trimethylation (H3K27me3) this is hypothesized to be a driving event of DIPG oncogenesis. Pontine is
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A molecular informed therapy for Diffuse Intrinsic Pontine Gliomas (DIPG)
  • 批准号:
    10654155
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2022
  • 负责人:
    Andrea Piunti
  • 依托单位:
A molecular informed therapy for Diffuse Intrinsic Pontine Gliomas (DIPG)
  • 批准号:
    10708134
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2022
  • 负责人:
    Andrea Piunti
  • 依托单位:
海外基金